AMG-811

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAMG-811
Drug Alias NameAMG-811
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterferon gamma inhibitors
TargetsInterferon gamma
Therapy Area/IndicationsPsoriasisLupus Erythematosus, SystemicLupus Erythematosus, Discoid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisLupus Erythematosus, SystemicLupus Erythematosus, Discoid +[5] 

Other Information

ATC CodeN/A
Related LinksN/A